Complement activation is an important mediator of kidney injury in glomerulonephritis. Complement factor H (FH) and FH-related protein 5 (FHR-5) influence complement activation in C3 glomerulopathy and IgA nephropathy by differentially regulating glomerular complement. FH is a negative regulator of complement C3 activation. Conversely, FHR-5 in vitro promotes C3 activation either directly or by competing with FH for binding to complement C3b. The FH-C3b interaction is enhanced by surface glycosaminoglycans (GAGs) and the FH-GAG interaction is well-characterized. In contrast, the contributions of carbohydrates to the interaction of FHR-5 and C3b are unknown. Using plate-based and microarray technologies we demonstrate that FHR-5 interacts wi...
The mechanisms that link complement activation and glomerular injury are not understood. Recently, n...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement activation at a particular location is determined by the balance of activating and inhibi...
The complement system is an integral component of innate immunity. Complement activation is tightly...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Introduction Therapeutic agents that target complement are increasingly available for glomerular dis...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement factor H (FH) inhibits complement activation and interacts with glomerular endothelium vi...
Complement factor H (FH) inhibits complement activation and interacts with glomerular endothelium vi...
The mechanisms that link complement activation and glomerular injury are not understood. Recently, n...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement activation at a particular location is determined by the balance of activating and inhibi...
The complement system is an integral component of innate immunity. Complement activation is tightly...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Introduction Therapeutic agents that target complement are increasingly available for glomerular dis...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement factor H (FH) inhibits complement activation and interacts with glomerular endothelium vi...
Complement factor H (FH) inhibits complement activation and interacts with glomerular endothelium vi...
The mechanisms that link complement activation and glomerular injury are not understood. Recently, n...
Complement dysregulation is characteristic of the renal diseases atypical hemolytic uremic syndrome ...
Complement activation at a particular location is determined by the balance of activating and inhibi...